Your browser doesn't support javascript.
loading
The role of interleukin-17 in tumor development and progression.
Zhao, Junjie; Chen, Xing; Herjan, Tomasz; Li, Xiaoxia.
Afiliação
  • Zhao J; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH.
  • Chen X; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH.
  • Herjan T; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH.
  • Li X; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH.
J Exp Med ; 217(1)2020 01 06.
Article em En | MEDLINE | ID: mdl-31727782
ABSTRACT
IL-17, a potent proinflammatory cytokine, has been shown to intimately contribute to the formation, growth, and metastasis of a wide range of malignancies. Recent studies implicate IL-17 as a link among inflammation, wound healing, and cancer. While IL-17-mediated production of inflammatory mediators mobilizes immune-suppressive and angiogenic myeloid cells, emerging studies reveal that IL-17 can directly act on tissue stem cells to promote tissue repair and tumorigenesis. Here, we review the pleotropic impacts of IL-17 on cancer biology, focusing how IL-17-mediated inflammatory response and mitogenic signaling are exploited to equip its cancer-promoting function and discussing the implications in therapies.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interleucina-17 / Carcinogênese / Neoplasias Limite: Animals / Humans Idioma: En Revista: J Exp Med Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interleucina-17 / Carcinogênese / Neoplasias Limite: Animals / Humans Idioma: En Revista: J Exp Med Ano de publicação: 2020 Tipo de documento: Article